4//SEC Filing
Yarema Kristin 4
Accession 0001209191-21-017037
CIK 0001604464other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:15 PM ET
Size
7.7 KB
Accession
0001209191-21-017037
Insider Transaction Report
Form 4
Yarema Kristin
Chief Commercial Officer
Transactions
- Award
Common Stock
2021-03-01+35,021→ 92,289 total - Award
Employee Stock Option (Right to Buy)
2021-03-01+52,862→ 52,862 totalExercise: $17.11Exp: 2031-02-28→ Common Stock (52,862 underlying)
Footnotes (3)
- [F1]These restricted stock units vest in 16 equal quarterly installments on each Company Quarterly Vesting Date (as defined below), with the initial installment vesting on May 15, 2021, subject to the reporting person's continuous service. Company Quarterly Vesting Date means March 1, May 15, August 15 and November 15 of each year.
- [F2]Includes 2,268 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on November 30, 2020.
- [F3]1/48th of the shares subject to the stock option vest and become exercisable each month with the initial installment vesting on April 1, 2021, subject to the reporting person's continuous service.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001803794
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 5:15 PM ET
- Size
- 7.7 KB